Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRU vs. JNGLX: which is better?

Bottom line

PRU vs JNGLX: the short answer

PRU (Pruco Life Variable Appreciable Account) and JNGLX (Janus Henderson Global Life Sciences Fund) are both etfs.

Updated Nov 19, 2026

PRU vs JNGLX side by side

PRUJNGLX
TypeETFMutual fund
Fund familyPruco Life Variable Appreciable AccountJanus Henderson
CategoryOtherGlobal Stock
Expense ratio—0.81%
Annual cost per $10k—$81
10-yr cost on $10k (prospectus)—$1,002
Max front loadNone—
12b-1 fee——
1-yr return——
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter—+21.0%
Worst quarter—−13.6%
Net assets (fund)—$5.8B
Number of holdings—108
Portfolio turnover—3%
Returns as of——

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

PRU and JNGLX share none of their top holdings.

PRU top 10

    JNGLX top 10

    1. Eli Lilly & Co. — 9.41%
    2. Johnson & Johnson — 7.09%
    3. AbbVie, Inc. — 4.67%
    4. UnitedHealth Group, Inc. — 4.54%
    5. AstraZeneca plc — 3.93%
    6. Revolution Medicines, Inc. — 3.02%
    7. Argenx SE — 2.63%
    8. Novartis AG — 2.56%
    9. Thermo Fisher Scientific, Inc. — 2.33%
    10. Praxis Precision Medicines, Inc. — 2.19%

    FAQ

    What is the difference between PRU and JNGLX?
    PRU (Pruco Life Variable Appreciable Account) and JNGLX (Janus Henderson Global Life Sciences Fund) are both etfs.
    Should I own both PRU and JNGLX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.